McKesson Corporation (MCK) Stock
NYSEMCK has an Alpha Score of 52 out of 100 (weak), computed on Nov 12, 2026 from 3 of 4 sub-scores. 26 members of Congress disclosed 75 trades in MCK since 2014: 44 purchases and 31 sales, most recently Rick Larsen (purchase, Jul 8, 2026). 7 of the hedge funds AlphaScala tracks reported MCK in 13F filings for the quarter ended Sep 30, 2026; the largest reported position is D.E. Shaw's at $365.59M. Company insiders reported 0 open-market buys and 4 sales on SEC Form 4 in the 90 days to Nov 13, 2026. Its trailing P/E ratio is 26.4 and its net margin 1.1% (key statistics as of Nov 12, 2026).
What is MCK's Alpha Score?
How it works →Alpha Score of 52 reflects moderate overall profile with strong momentum, poor value, moderate quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 12, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded McKesson Corporation (MCK)?
Most recent: Rick Larsen (purchase, Jul 8, 2026); records start Feb 6, 2014.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Rick Larsen D-WA · House | 2026-07-08 | purchase | $1k – $15k |
| Jonathan Jackson D-IL · House | 2026-06-15 | sale | $1k – $15k |
| Lizzie Fletcher D-TX · House | 2026-04-08 | partial sale | $1k – $15k |
| Alan Armstrong R-OK · Senate | 2026-03-27 | purchase | $1k – $15k |
| Markwayne Mullin R-OK · Senate | 2026-02-04 | purchase | $15k – $50k |
| Markwayne Mullin R-OK · Senate | 2026-01-05 | purchase | $15k – $50k |
| Gil Cisneros D-CA · House | 2025-12-19 | sale | $1k – $15k |
| Jared Moskowitz D-FL · House | 2025-12-02 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 12, 2026. Senate records here end Nov 4, 2026; later Senate trades are not included.
Every member of Congress who traded MCK, with filing lags →Which hedge funds own MCK?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| D.E. Shaw David Shaw | 484K | $365.59M | +807% |
| Citadel Ken Griffin | 460K | $347.89M | +512% |
| Renaissance Technologies Jim Simons (founder) | 195K | $166.63M | -46% |
| Millennium Management Israel Englander | 101K | $76.42M | +76% |
| Point72 Steve Cohen | 72K | $54.36M | NEW |
| Bridgewater Associates Ray Dalio | 70K | $53.16M | +4% |
| Lone Pine Capital Steve Mandel | 58K | $43.71M | -85% |
13F holdings as of Sep 30, 2026
Explore all tracked funds →Are McKesson Corporation insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Nov 5, 26 | Fraga Francisco | EVP, CIO and CTO | SELL | 650 | $717K |
| Nov 4, 26 | Fraga Francisco | EVP, CIO and CTO | SELL | 600 | $630K |
| Oct 15, 26 | Fraga Francisco | EVP, CIO and CTO | SELL | 800.491 | $797K |
| Sep 8, 26 | Rutledge Napoleon B Jr | SVP, Controller & CAO | SELL | 111 | $99K |
| Aug 10, 26 | Lerman Bradley E | Director | SELL | 301 | $269K |
| Mar 2, 26 | Lau Michele | EVP and Chief Legal Officer | SELL | 2.7K | $2.7M |
| Feb 19, 26 | Martinez Maria | Director | SELL | 349 | $328K |
| Feb 17, 26 | Smith Leann B | EVP & Chief HR Officer | SELL | 190 | $180K |
| Feb 11, 26 | Lau Michele | EVP and Chief Legal Officer | SELL | 303 | $283K |
| Feb 6, 26 | Rutledge Napoleon B Jr | SVP, Controller & CAO | SELL | 328 | $313K |
SEC Form 4 filings as of Nov 13, 2026
See cluster-buy signals across all tickers →What are MCK's key statistics?
Key statistics as of Nov 12, 2026
How does MCK's valuation compare with the Healthcare sector?
| Metric | MCK | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 26.4 | 28.4 | 131 |
| Net margin | 1.12% | 3.58% | 199 |
| Return on equity | 39.43% | 2.96% | 226 |
| Dividend yield (payers) | 0.54% | 1.37% | 57 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 16, 2026). P/E excludes loss-making companies.
MCK price chart
Powered by TradingViewWhat does McKesson Corporation do?
McKesson Corporation is a leading diversified healthcare services company specializing in pharmaceutical distribution and supply chain management solutions. It operates primarily through key segments including North American Pharmaceutical, which sources and distributes branded, generic, and specialty drugs to retail pharmacies, hospital networks, and healthcare providers; Oncology & Multispecialty, focusing on provider and specialty distribution growth; Prescription Technology Solutions, offering third-party logistics and technology services for pharmacies; and Medical-Surgical Solutions, supplying medical products and equipment to healthcare facilities. McKesson also engages in pharmaceutical wholesale in Canada and provides technology solutions enhancing access and efficiency in healthcare delivery. As one of three dominant players accounting for over 90% of the U.S. pharmaceutical wholesale market, alongside peers like Cencora and Cardinal Health, it partners with manufacturers, providers, pharmacies, and governments to ensure safe, timely, and cost-effective delivery of medicines and services. Founded in 1833 and headquartered in Irving, Texas, McKesson Corporation plays a critical role in the global healthcare ecosystem.